Cynthia Lambert Hardman has over a decade of experience litigating complex intellectual property cases, from developing initial strategy through appeal. She has appeared in cases before federal district courts, the U.S. Court of Appeals for the Federal Circuit, and the International Trade Commission. Her extensive experience has earned her a spot on the 2012 and 2013 editions of Super Lawyers New York–Metro Rising Stars.
Ms. Hardman has represented clients in the pharmaceutical, medical device, nutritional supplement and consumer product industries. She has significant experience with ANDA patent litigation under the Hatch-Waxman Act, and has also litigated cases involving a wide range of products such as spinal fixation devices, home pregnancy tests, and video content analysis systems and software.
Ms. Hardman’s practice also extends to pre-litigation counseling, including rendering opinions relating to patentability, infringement, validity and freedom-to-operate issues. She has also conducted due diligence in connection with acquisitions of patent estates. Additionally, Ms. Hardman is a founder and editor of Kenyon’s CAFC Blog (www.cafcblog.com), which follows the latest IP decisions from the Federal Circuit.
- Teva Pharmaceuticals, defending against a multi-billion dollar damages claim in a case relating to Pfizer’s epilepsy drug Neurontin (gabapentin). Defendants succeeded in barring several of Pfizer’s expert witness opinions at trial. The 10 year-old dispute settled two weeks into an expected seven-week jury trial. Pfizer v. Teva Pharmaceuticals USA et al. (D.N.J.)
- Watson in an ANDA bench trial regarding patents for treatment of overactive bladder. Allergan et al. v. Watson Laboratories et al. (D. Del.)
- Teva Pharmaceuticals in an action involving patents for Abbott’s antibiotic Biaxin XL (clarithromycin). Helped overturn a preliminary injunction, allowing Teva to market its generic equivalent of the drug. Abbott Laboratories v. Andrx Pharmaceuticals et al. (N.D. Ill.)
- MuscleTech in a trademark and copyright counterfeiting case, which also involved RICO claims, relating to sports nutrition supplements sold under Iovate Health Sciences’ MuscleTech label. Case resulted in an award, on summary judgment, of $5.7 million plus attorneys’ fees. MuscleTech Research & Development v. East Coast Ingredients (W.D.N.Y.)
- Teva in case relating to patents for Pfizer’s antibiotic Zithromax (azithromycin). Pfizer v. Teva Pharmaceuticals USA et al. (S.D.N.Y.)
- Blackstone Medical in patent case relating to methods and devices for spinal fixation. Medtronic Sofamor Danek USA et al. v. Blackstone Medical (D. Mass.)
- Princeton Biomeditech in case involving home pregnancy test patents. Inverness Medical Switzerland GmbH et al. v. Princeton Biomeditech (D.N.J.)